Susanne Herold
Experienced in Mycobacterium Avium Complex Infections

Susanne Herold

Giessen, HE, DE 
Experienced in Mycobacterium Avium Complex Infections
Giessen, HE, DE 
OverviewLocationsClinical Research

Overview

Susanne Herold practices in Giessen, Germany. Ms. Herold is rated as an Experienced expert by MediFind in the treatment of Mycobacterium Avium Complex Infections. Her top areas of expertise are Pneumonia, Flu, Acute Respiratory Distress Syndrome (ARDS), Splenectomy, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 178 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Mycobacterium Avium Complex Infections.

Gender
Female

Locations

Giessen, HE, Germany
Other Locations
Erlangen, BY, Germany
Heidelberg, BW, Germany
Hessen, ST 35392, Germany
Berlin, BE, Germany
Bad Nauheim, HE, Germany
Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

GM-CSF Inhalation to Improve Host Defense and Pulmonary Barrier Restoration (GI-HOPE). A Randomized, Double-blind, Parallel Group, Multicenter, Phase II Study
GM-CSF Inhalation to Improve Host Defense and Pulmonary Barrier Restoration (GI-HOPE). A Randomized, Double-blind, Parallel Group, Multicenter, Phase II Study
Enrollment Status: Completed
Publish Date: August 31, 2023
Intervention Type: Drug
Study Drug: Molgramostim
Study Phase: Phase 2
Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Inhalation to Prevent ARDS in COVID-19 Pneumonia (GI-COVID)
Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Inhalation to Prevent ARDS in COVID-19 Pneumonia (GI-COVID)
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Drug, Other
Study Drug: Molgramostim
Study Phase: Phase 2
View 1 Less Clinical Trial

178 Total Publications

Bedaquiline-Pretomanid-Linezolid as a Bridging Therapy for Adverse Events in Drug-Sensitive Tuberculosis.
Bedaquiline-Pretomanid-Linezolid as a Bridging Therapy for Adverse Events in Drug-Sensitive Tuberculosis.
Journal: American journal of respiratory and critical care medicine
Published: July 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Herold's expertise for a condition
ConditionClose
    View All 25 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile